<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>Carcinogenesis vol.34 11 pp.2647&#226;&#8364;&#8220;2654, 2013 <br /> doi:10.1093/carcin/bgt217 <br /> Advance Access publication June 12, 2013 <br />  <br /> IMP1 promotes tumor growth, dissemination tumor-initiating cell phenotype colorectal cancer cell xenografts <br />  <br /> Kathryn E.Hamilton1,&#226;&#8364;&#160;, Felicite K.Noubissi2,&#226;&#8364;&#160;, Prateek                           termed &#226;&#8364;&#732;oncofetal&#226;&#8364;&#8482; factor role development <br /> S.Katti1, Christopher M.Hahn1, Sonya R.Davey1, Emma                              carcinogenesis. <br /> T.Lundsmith1, Andres J.Klein-Szanto3, Andrew D.Rhim1,                               Mechanistically, IMP1 described variety roles Vladimir S.Spiegelman2,4 Anil K.Rustgi1,5,6,*                                vitro, including mRNA trafficking translational stabilization                                                                                  various genes. addition, studies IMP1 orthologs 1 <br />  Division Gastroenterology, Department Medicine, University             demonstrated specific roles IMP1 cytoskeletal organization Pennsylvania, Philadelphia, PA 19104, USA, 2Department Dermatology,           cellular movement (2,11&#226;&#8364;&#8220;13). Imp1 shown bind University Wisconsin School Medicine Public Health, Madison,           stabilize &#206;&#178;-TrCP1 mRNA upstream Skp-1-Cullin1-F-box E3 ubiq- <br /> WI 53706, USA, 3Department Pathology, Fox Chase Cancer Center,                uitin ligase activation, leads increased turnover I&#206;&#186;B Philadelphia, PA 19111, USA, 4Paul P.&#194;&#160;Carbone Comprehensive Cancer               &#206;&#178;-catenin (14). recently, studies reported IMP1 Center, University Wisconsin School Medicine Public Health, <br /> Madison, WI 53706, USA 5Abramson Cancer Center 6Department                                                                                  regulate cellular migration polarization regulation MAPK4 <br /> Genetics, University Pennsylvania, Philadelphia, PA 19104, USA                PTEN osteosarcoma ovarian tumor cell lines                                                                                  promote wound repair colonic mesenchymal stem cells stabili- <br />  correspondence addressed. Tel:&#194;&#160;+1 215 898 0154;               zation Ptgs2 mRNA (15,16). Collectively, studies suggest Fax: +1 215 573 2024;                                                            multitude roles IMP1 explain clinical observations Email: anil2@mail.med.upenn.edu <br /> Correspondence addressed Vladimir Spiegelman. <br />                                                                                  context cancer development progression.  Tel:&#194;&#160;+1 608 265 8197; Fax: +1 608 263 5223;                                      functional roles remain largely untested vivo. <br /> Email: spiegelman@dermatology.wisc.edu                                              Despite potential diagnostic therapeutic importance                                                                                  human cancers, study addressed direct role IMP1 <br /> Igf2 mRNA binding protein 1 (IMP1, CRD-BP, ZBP-1) mes-                      tumorigenesis vivo <span id='am-1' about='oboInOwl:date' typeof='owl:Thing'>date</span>. Transgenic expression Imp1 driven <br /> senger RNA binding protein shown previously reg-                 whey acidic protein promoter, expressed mammary <br /> ulate colorectal cancer (CRC) cell growth vitro. Furthermore,                 epithelium pregnant lactating females, led breast tumors increased IMP1 expression correlates enhanced metastasis                    95% transgenic mice compared controls, subset mice poor prognosis CRC patients. current study,                     exhibiting metastatic disease (7). compelling,  <br /> sought elucidate IMP1-mediated functions CRC pathogene-                    ings limited breast neoplasia relatively long tumor latency. <br /> sis vivo. Using CRC cell xenografts, demonstrate IMP1                 Importantly, tumors whey acidic protein Imp1 mice did overexpression promotes xenograft tumor growth dissemina-                    exhibit upregulation c-Myc Igf2 protein levels, indicating role <br /> tion blood. Furthermore, intestine-specific knockdown                pathways directly indirectly influenced IMP1 Imp1 dramatically reduces tumor number ApcMin/+ mouse                     tumor initiation progression. <br /> model intestinal tumorigenesis. addition, IMP1 knockdown                      IMP1 expressed rare populations cells normal adult <br /> xenografts exhibit reduced number tumor cells entering                  intestine (10 unpublished observations). Furthermore, human CRC <br /> circulation, suggesting IMP1 directly modulate                     tumors exhibit high IMP1 expression correlate enhanced <br /> early metastatic event. demonstrate IMP1                    metastasis recurrence, IMP1 positive tumors correlate expression decreases E-cadherin expression, promotes survival                    shorter survival time (10). shown previously IMP1 loss single tumor cell-derived colonospheres promotes enrich-                  decreases proliferation colony formation CRC cell lines ment maintenance population CD24+CD44+ cells,                        high IMP1 expression correlated positively &#206;&#178;-catenin <br /> signifying IMP1 overexpressing cells display evidence loss               K-ras activation primary colorectal tumors predicts poor epithelial identity enhancement tumor-initiating cell                clinical outcome CRC patients (17).  present data indicat- <br /> phenotype. Taken  findings implicate IMP1                    ing IMP1 overexpression promotes tumor-cell growth CRC <br /> modulator tumor growth provide evidence novel role                  xenografts intestine-specific Imp1 knockdown reduces tumor IMP1 early events CRC metastasis.                                       number genetic mouse model intestinal tumorigenesis. addi- <br />                                                                                  tion, xenograft mice IMP1 overexpressing CRC cells exhibited <br />                                                                                  enhanced dissemination blood, knockdown IMP1 <br />                                                                                  decreased number circulating tumor cells. Furthermore, IMP1 <br /> Introduction                                                                     promotes tumor-initiating cell phenotype vitro. Taken  <br /> Igf2 mRNA binding protein 1 (IMP1, CRD-BP, ZBP-1) mes-                      data support role IMP1 modulating CRC tumor growth <br /> senger RNA (mRNA) binding protein originally identified trans-              indicate IMP1 potential initiator metastasis promoting <br /> lational stabilizer c-Myc, &#206;&#178;-actin Igf2 mRNAs (1&#226;&#8364;&#8220;4). IMP1                 tumor-cell dissemination blood. expressed ubiquitously development mice, low <br /> expression adult tissues, function adulthood remains           Materials methods <br /> unclear (5). Global Imp1 deletion mice leads dwarfism                                                                                  Generation IMP1 overexpression knockdown cell&#194;&#160;lines <br /> lethal intestinal phenotype near birth, suggesting particularly <br /> critical role Imp1 fetal development intestine (5).             SW480 LoVo cell stocks obtained commercially American Type <br />                                                                                  Culture Collection (Manassas, VA) previously authenticated humans, IMP1&#226;&#8364;&#8482;s aberrant reexpression implicated various <br />                                                                                  Rustgi laboratory cytogenetic analyses. Cells maintained according <br /> cancers, including colon, lung, skin breast (5&#226;&#8364;&#8220;10).  IMP1               American Type Culture Collection recommendations. IMP1/pMSCV- <br />                                                                                  PIG retroviral vector (plasmid 21659)&#194;&#160; control vector purchased <br />                                                                                  Addgene (Cambridge, MA) used stably infect SW480 LoVo <br /> Abbreviations:&#226;&#8364;&#8218;CRC, colorectal cancer; EMT, epithelial mesenchymal            cells (described previously) (17,18). shown previously IMP1 <br /> transition; GFP, green fluorescent protein; IMP1, Igf2 mRNA binding protein 1;   knockdown decreases cell proliferation using multiple small interfering RNAs <br /> MEF, mouse embryonic fibroblast; mRNA, messenger RNA; qRT&#226;&#8364;&#8220;PCR, quan-             (17), opted generate inducible IMP1 short hairpin RNA cell line. <br /> titative reverse transcription&#226;&#8364;&#8220;polymerase chain reaction; RFP, red fluorescent   achieved transducing SW480 cells doxycycline-inducible <br /> protein; TIC, tumor-initiating cell.                                             short hairpin RNA pTripz lentiviral vector (Open Biosystems, Huntsville, <br />                                                                                  AL, clone <span id='am-7' about='oboInOwl:id' typeof='owl:Thing'>ID</span> V3THS_342778). overexpression knockdown <br /> &#226;&#8364;&#160; authors contributed equally work.                                  experiments, transduced cells selected using puromycin necessary <br />  <br /> &#194;&#169; Author 2013. Published Oxford University Press. rights reserved. Permissions, email: journals.permissions@oup.com                2647 <br />  K.E.Hamilton et&#194;&#160;al. <br />  <br />  <br />  <br /> sorted Penn Flow Cytometry Cell Sorting Core obtain greater          (Chemicon, Billerica, MA). Mouse monoclonal antibody Imp1 99% efficiency. IMP1 overexpression knockdown confirmed using          generated Spiegelman Laboratory. <br /> quantitative reverse transcription&#226;&#8364;&#8220;polymerase chain reaction (qRT&#226;&#8364;&#8220;PCR), <br /> western blotting fluorescent imaging overexpression [green           Immunostaining <br /> fluorescent protein (GFP)] knockdown [red fluorescent protein (RFP)].           week old Imp1-loxP+/+;Villin-Cre+/&#226;&#710;&#8217; (Imp1-loxP homozygous; Villin- <br />                                                                                    Cre heterozygous) mice littermate wild-type mice euthanized Gene expression analysis                                                           <span id='am-2' about='obo:IMR_0200324' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-3' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-4' property="oboInOwl:id" content="IMR:0200324" datatype="xsd:string"></span><span id='am-5' property="rdfs:label" content="CO2" datatype="xsd:string"></span><span id='am-6' property="oboInOwl:hasDbXref" content="KEGG:C00011" datatype="xsd:string"></span>CO2</span> asphyxiation followed cervical dislocation, intestines Cell lines monitored IMP1 overexpression knockdown qPCR        collected, preserved 10% formalin 48 h 70% ethanol. Cross- probe-specific complementary DNA using following proprietary primer/       tissue sections generated formalin-fixed paraffin-embedded intes- <br /> probe sets: IGF2BP1 Hs00198023_m1; GAPDH Hs99999905_m1 (Applied                    tine. sections subsequently deparaffinized xylene (Fisher, NJ) <br /> Biosystems, Carlsbad, CA) using ABI Prism 7000 Sequence Detection           rehydrated grades alcohol. sections subjected antigen <br /> Additional primer/probe sets include following: CDH1 Hs01023894_m1;            retrieval incubating 10&#226;&#8364;&#8240;mM citrate buffer 20 min microwave oven. <br /> VIM Hs00185584_m1; SNAI1 Hs00195591_m1; SNAI2 Hs00161904_m1;                       sections blocked normal goat serum, probed specific pri- <br /> ZEB1 Hs00232783_m1; ZEB2 Hs00207691_m1. western blotting, cells                mary antibodies Imp1, followed appropriate fluorescent-labeled second- lysed radioimmunoprecipitation assay buffer [phosphate-buffered saline     ary antibody (Invitrogen, Carlsbad, CA). Tissue sections mounted (pH 7.4), 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate, 1% (v/v)          Prolong Gold Antifade 4&#226;&#8364;&#178;,6-diamidino-2-phenylindole mounting media <br /> IGEPAL, 100&#226;&#8364;&#8240;   mM sodium orthovanadate proteinase inhibitor cocktail           (Invitrogen). <br /> (Sigma, St Louis, MO)]. Protein quantified BCA Protein Assay Kit <br /> (Thermo Scientific, Rockford,  loaded 4&#226;&#8364;&#8220;12% gradient gels electro-   Tumor&#194;&#160;count <br /> phoresis using Invitrogen (Carlsbad, CA) western blotting apparatus. Antibodies    Imp1-loxP+/+ mice crossed sequentially Villin-Cre ApcMin+/&#226;&#710;&#8217; <br /> used follows: rabbit anti-IMP1 (Cell Signaling, Danvers, MA); mouse        mice obtain Imp1-loxP+/&#226;&#710;&#8217;; Villin-Cre+/&#226;&#710;&#8217;;ApcMin/+ Villin-Cre+/&#226;&#710;&#8217;;ApcMin/+ <br /> anti-GAPDH (Millipore, Billerica, MA).                                             animals. 90&#194;&#160; days age, mice euthanized CO2 asphyxiation <br />                                                                                    followed cervical dislocation, different parts intestine Xenograft&#194;&#160;tumors                                                                   collected, opened preserved 10% formalin 48 h 70% <br /> Athymic nude mice (6-weeks-old, mice group, Taconic,            ethanol. tumors counted microscope. Mann&#226;&#8364;&#8220;Whitney U- <br /> Cranbury, NJ) injected rear flank 1 &#195;&#8212; 106 IMP1 overexpressing     test used statistical analysis. knockdown cells vector cells suspended BD Matrigel&#226;&#8222;&#162; Basement <br /> Membrane Mix (San Jose, CA) described previously (18). mice cared      Analysis circulating tumor cells accordance University Laboratory Animal Resources requirements         Analysis circulating tumor cells performed described previously Institutional Animal Care Use Committee approved protocol.        (20). Briefly, immediately posteuthanasia, blood collected mice <br /> Mice evaluated weekly 8 weeks postinjection tumors measured           using 1 ml syringes containing 0.1 ml chilled lithium heparin cardiac punc- <br /> manually using digital calipers. Mice euthanized 8 weeks postinjection     ture. Samples enriched negative selection erythrocytes using FACS <br /> sooner accordance Institutional Animal Care Use Committee guide-       Lyse buffer (BD Biosciences) analyzed 10% fetal calf serum/Dulbecco&#226;&#8364;&#8482;s <br /> lines tumor size animal welfare. Mice IMP1 knockdown given       modified Eagle&#226;&#8364;&#8482;s medium/F12 using Accuri C6 Flow Cytometer. Pulse <br /> doxycycline (2 g/l 5% sucrose water) 1 week postinjection duration   height forward scatter scatter gating used gate dead cells, study. Live animal imaging IMP1 knockdown xenograft mice            high expression GFP RFP correlated live cells. number <br /> formed using IVIS imaging (Xenogen, Alameda, CA)            GFP RFP positive cells milliliter blood calculated. Small Animal Imaging Core Facility University Pennsylvania.         analyzed blood mice group. <br /> imaging served additional measure tumor volume knockdown stud- <br /> ies, confirmation knockdown maintained  visualization   Colonosphere&#194;&#160;assay <br /> RFP) duration study. Portions tumors harvested 10% <br />                                                                                    euthanized, half xenograft tumor used sort <br /> formalin histology, hematoxylin eosin staining performed                                                                                    single, live tumor cells 96 utlralow attachment plates assay tumors, staining collagen using Masson&#226;&#8364;&#8482;s trichrome. Slides                                                                                    colonosphere growth described previously (21). Briefly, tumors evaluated pathologist tumor morphology  J.K.-S.). <br />                                                                                    minced 1 mm3 pieces subjected sequential collagenase <br />                                                                                    (Sigma), trypsin/ethylenediaminetetraacetic acid (Invitrogen) DNase/ <br /> Generation Imp1-loxP&#194;&#160;mice                                                       Dispase (Roche, Indianapolis,  digestions. Single-cell suspensions Mice heterozygous Imp1-loxP generated Ozgene (www.Ozgene.com),         obtained filtering cell suspensions 40 &#206;&#188;M filter. Single GFP+ homozygous Imp1-loxP mice obtained house breed-         tumor cells sorted using BD FACS Aria assistance ing. Genotype mice confirmed PCR using primers loxP arm      UPenn Flow Cytometry Cell Sorting Facility. Dead cells excluded following sequences; loxP arm 1F: 5&#226;&#8364;&#178;TGTGTGTGTGTGAGGGAGGT3&#226;&#8364;&#178;;               using 4&#226;&#8364;&#178;,6-diamidino-2-phenylindole staining. tumor cell sorted loxP arm 1R: 5&#226;&#8364;&#178;TAGGTGACGTTGACCACAGC3&#226;&#8364;&#178;. Native gels 15%                     96 ultralow attachment plates (Corning  Lowell, MA) <br /> used differentiate mice homozygous Imp1-loxP, showed        containing 100 &#206;&#188;l prewarmed serum-free &#226;&#8364;&#732;stem cell media&#226;&#8364;&#8482; (Dulbecco&#226;&#8364;&#8482;s <br /> PCR product size 270 bp, wild-type mice (235 bp) mice heterozygous      modified Eagle&#226;&#8364;&#8482;s medium/F12, B27 (Life Technologies, Gaithersburg, MD), Imp1-loxP, showed PCR product sizes.                                20 ng/ml epidermal growth factor (Sigma), 10 ng/ml fibroblast growth factor <br />                                                                                    (Sigma). Tumors mice condition analyzed number <br /> Generation characterization mouse embryonic fibroblasts                     spheres 96 plate, sphere size analyzed photographing homozygous female Imp1-loxP mouse mated homozygous male               individual spheres measuring radii using NIH ImageJ. Data represented <br /> Imp1-loxP mouse. 14&#194;&#160;days gestation, female euthanized using          mean &#194;&#177; standard error. passaging, colonospheres mechanically <br /> isoflurane anesthesia followed cervical dislocation. Embryos           dissociated removing single spheres new 96 ultralow attachment <br /> removed uterus used generate mouse embryonic fibroblasts           plate containing stem cell media vigorous pipetting (25 times) break <br /> (MEFs) according WiCell protocol (WiCell, Madison, WI, http://www.          apart individual spheres. Successful dissociation determined immediately <br /> wicell.org). Briefly, aseptic conditions, embryos cleaned     following passaging visualization light microscopy. Fourteen days <br /> visceral tissue, washed times phosphate-buffered saline,         postpassaging, total growth new spheres spheres &#226;&#8364;&#732;spreading&#226;&#8364;&#8482; minced grain-sized pieces using dissecting scissors, mixed tryps         &#226;&#8364;&#732;budding&#226;&#8364;&#8482; evaluated blind scoring (P.S.K.) total growth ethylenediaminetetraacetic acid (0.25% trypsin/2.21 mM ethylenediami-           individual wells, score 0 zero living, GFP+ cells <br /> netetraacetic acid; Mediatech, Herndon, VA) placed 37&#194;&#176;C tissue cul-       remaining score 10 100% coverage GFP+ <br /> ture incubator 20 min. derivation culture media added          spheres budding spheres. minced tissue mixture transferred different T75 flasks placed 37&#194;&#176;C tissue culture incubator overnight. Attached MEFs         Fluorescence-activated cell-sorting analysis CD24+CD44+&#194;&#160;cells observed day cells propagated. cell lysates       Single-cell suspensions prepared stable IMP1 overexpression MEFs transfected Cre expression vector vector         cells (SW480). Cells trypsinized cell culture plates, resuspended <br /> lysed using radioimmunoprecipitation assay buffer. Immunoblotting proce-           complete media, passed 70 &#206;&#188;m cell strainer, rinsed fluo- <br /> dures performed described previously (19). Western blot antibody           rescence-activated cell-sorting buffer (phosphate-buffered saline/1% bovine &#206;&#178;-actin (Santa Cruz Biotechnology, Santa Cruz, CA) purchased,          serum albumin) stained following antibodies: PE/Cy7 anti-human secondary antibody conjugated horseradish peroxidase           CD24 (BioLegend, San Diego, CA); APC anti-human CD44 (BD Biosciences, <br />  <br /> 2648 <br />                                                                                                                       IMP1 colorectal cancer cell xenografts <br />  <br />  <br />  <br /> San Jose, CA). Flow cytometry using BD FACS Calibur (BD                   rear flanks nude mice monitored tumor growth weekly <br /> Biosciences), data analyzed using FlowJo Flow Cytometry Analysis            course 8 weeks. significant increase SW480 <br /> Software. functional analyses CD24+CD44+ cells, 25%              xenograft tumor volume mice IMP1 overexpression 8 weeks <br /> collected CD24+CD44+high, remaining cells (CD24+CD44+ neg/low                postinjection (Figure&#194;&#160;1B). significant difference total <br /> expression) using BD FACS Aria assistance UPenn Flow <br /> Cytometry Cell Sorting Facility. Cells immediately plated                                                                                      body weights control IMP1 overexpression groups (data <br /> polystyrene tissue culture plates passaged trypsinization 70&#226;&#8364;&#8220;90%          shown). control IMP1 overexpressing tumors confluence. Passaged cells subsequently characterized CD24+CD44+            poorly differentiated adenocarcinoma significant differences <br /> expression FACS Calibur, proportions CD24+CD44+high cells              tumor morphology histopathological analysis (Figure&#194;&#160; 1C), analyzed using FlowJo Flow Cytometry Analysis Software. Unsorted                significant difference collagen deposition MSCV-IMP1 cells used create standardized gate experimen-          control overexpression tumors (data shown). second, <br /> tal passage, 20% cells present gated CD24+CD44+.              independent overexpression CRC cell line, LoVo cells, observed normalized gating unsorted population allowed compare rela-         increased tumor burden IMP1 overexpression 2.5 weeks <br /> tive proportion CD24+CD44+ cells control versus IMP1 overexpressing            postinjection;  primary tumors grew rapidly, resulting <br /> cells. Cells analyzed passage 0&#226;&#8364;&#8220;3, data represented relative <br /> difference control IMP1 overexpressing CD24+CD44+high cells <br />                                                                                      lesions required early euthanasia (Supplementary Figure S1, course passages.                                                   available Carcinogenesis Online). <br />                                                                                         order address IMP1 knockdown effects tumorigenesis, Statistical analyses                                                                 generated Imp1-loxP mice. mice, exons 5 6 flanked xenografts circulating tumor cells, statistical significance compari-     loxP sequences (design targeting construct Figure&#194;&#160;2A). <br /> sons vector IMP1 tumors determined applying stu-            effectiveness inducible knockout Imp1 animals dent&#226;&#8364;&#8482;s t-test, P &lt; 0.05 statistically significant. analyses,   verified MEFs isolated Imp1-loxP homozygous mouse <br /> data triplicate experiments presented mean &#194;&#177; standard          embryos.  dramatic reduction Imp1 expression achieved error analyzed applying student&#226;&#8364;&#8482;s t-test, P &lt; 0.05 statistically      MEFs transfected Cre recombinase expression <br /> significant.                                                                         plasmid (Figure&#194;&#160;2B). addition, shown expression <br />                                                                                      Cre recombinase Villin promoter (Imp1-loxP+/+;Villin- <br /> Results                                                                              Cre+/&#226;&#710;&#8217;) results significant inhibition Imp1 expression intes- <br />                                                                                      tinal epithelium mice (Figure&#194;&#160;2C). <br /> IMP1 modulates tumor volume vivo                                                     analyze contribution Imp1 ApcMin/+-driven intesti- <br /> IMP1 expression enhanced CRC tumors overexpres-                        nal tumorigenesis, shown previously express high <br /> sion correlates advanced disease poor prognosis humans.                  Imp1 small intestine colon tumors, crossed Imp1-loxP hypothesized overexpressing IMP1 drive                      mice sequentially Villin-Cre, ApcMin/+mice obtain Imp1- <br /> increase tumor volume potentially metastatic growth,                  loxP+/&#226;&#710;&#8217;;Villin-Cre+/&#226;&#710;&#8217;;ApcMin/+animals  Villin-Cre+/&#226;&#710;&#8217;ApcMin/+ litter- <br /> versely, IMP1 knockdown reduce tumor burden. assess                    mate controls) (23). observed robust 66% reduction total effect IMP1 overexpression knockdown CRC xenograft                      number intestinal tumors mice deficient expression <br /> tumor growth, initially chose SW480 cells express                    Imp1 intestinal epithelium (Figure&#194;&#160; 2D) 90&#194;&#160; days age, <br /> relatively moderate levels endogenous IMP1 shown                    signifying ApcMin/+-driven tumorigenesis inhibited intestinal-&#194;&#173; <br /> previously grow robust non-metastatic xenograft tumors (22).                  specific Imp1 knockdown. data, xenograft studies, <br /> IMP1 overexpression confirmed qRT&#226;&#8364;&#8220;PCR western blot-                       lead conclude IMP1 modulates primary tumor growth. <br /> ting consistently showed minimum 2-fold increase <span id='am-8' about='obo:IMR_0200221' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-9' property="oboInOwl:id" content="IMR:0200221" datatype="xsd:string"></span><span id='am-10' property="rdfs:label" content="IMP" datatype="xsd:string"></span><span id='am-11' property="oboInOwl:hasDbXref" content="KEGG:C00130" datatype="xsd:string"></span><span id='am-12' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>IMP</span>-1                      Surprisingly, did decrease tumor burden mice inje&#194;&#173; <br /> (Figure&#194;&#160;1A). performed subcutaneous injections 1 &#195;&#8212; 106 cells                   wcted SW480 IMP1 knockdown cells (Supplementary Figure S2, <br />  <br />  <br />  <br />  <br /> Fig.&#194;&#160;1.&#226;&#8364;&#8218; IMP1 overexpression increases tumor volume.   SW480 cells stably expressing MSCV MSCV-IMP1 assayed IMP1 expression. <br /> Glyceraldehyde 3-phosphate dehydrogenase used loading control. IMP1 expression significantly increased SW480 MSCV-IMP1 cells. *P &lt; 0.05, <br /> N = 3. (B) Xenograft mice injected control IMP1 overexpressing cells described Materials methods. Mean tumor volume significantly <br /> increased mice injected IMP1 overexpressing cells compared controls. *P &lt; 0.05, N = 8 mice group. (C) euthanized, xenograft <br /> tumors analyzed histologically. significant difference tumor histology IMP1 overexpression tumors compared control tumors. <br />  <br />                                                                                                                                                         2649 <br />  K.E.Hamilton et&#194;&#160;al. <br />  <br />  <br />  <br />  <br />                                                                                                                   B <br />                                                                                                                         Control     Cre <br />                                                                                                                                             Imp1 <br />                                                                                                                                             Actin <br />  <br />  <br />  <br />  <br />          C                                  Small Intestine                                            Colon <br />                                     Wild Type           Imp1-loxP+/+;                 Wild Type                 Imp1-loxP+/+; <br />                                                           Villin-Cre+/-                                          Villin-Cre+/- <br />  <br />  <br />                     Imp1 <br />  <br />  <br />  <br />  <br />                    DAPI <br />  <br />  <br />  <br />  <br />          Merged <br />  <br />  <br />  <br />  <br />          D               80 <br />           Tumor Number <br />  <br />  <br />  <br />  <br />                          60 <br />  <br />  <br />                          40 <br />                                               ** <br />                          20 <br />  <br />  <br />                          0 <br />                           Villin-Cre+/-; Imp1-loxP+/-; <br />                            ApcMin/+       Villin-Cre+/-; <br />                                            ApcMin/+ <br />  <br /> Fig.&#194;&#160;2.&#226;&#8364;&#8218; Intestinal-specific knockout Imp1 suppresses ApcMin/+-driven intestinal tumorigenesis.   Design targeting construct generation Imp1-LoxP <br /> mice. mice, exons 5 6 Imp1 flanked loxP sequences. (B) Immunoblot analysis protein extract isolated Imp1-loxP homozygous <br /> MEFs (transfected indicated) 48 h transfection. (C) Imp1 expression small intestine colon wild-type Imp1-loxP+/+; Villin-Cre+/&#226;&#710;&#8217; mice. <br /> Arrows indicate high expression Imp1. (D) Tumor number mouse intestine ApcMin/+-driven intestinal tumorigenesis. **P &lt; 0.001 Mann&#226;&#8364;&#8220;Whitney <br /> U-test, N &#226;&#8240;&#165; 5 mice group. <br />  <br /> available Carcinogenesis Online). ineffective                IMP1 modulates tumor dissemination blood <br /> knockdown, confirmed initially qRT&#226;&#8364;&#8220;PCR west-                       did observe gross metastases IMP1 overexpression <br /> ern blot monitored experiment using live animal                  xenograft models, consequence short time <br /> imaging RFP-expressing IMP1 short hairpin RNA-transduced                     course studies performed. circumvent limitation, cells. Viability analysis 4&#226;&#8364;&#178;,6-diamidino-2-&#194;&#173;phenylindole staining               evaluated burden tumor cells circulating blood, pathological analysis necrosis revealed greater            represents critical step metastatic cascade degree cell death IMP1 knockdown tumors (Supplementary                        newly emerging approach detection premalignant disease <br /> Figure S2, available Carcinogenesis Online), suggesting                 (20,26). collected blood cardiac puncture immediately <br /> haps unknown factor   compensating IMP1 loss-                 posteuthanasia utilized GFP RFP expressed tumor cell <br /> associated cell death cell line. analyzed expression              lines quantify tumor cells volume blood. SW480 cells, <br /> IMP1 paralog IMP3, increased CRC humans,                     IMP1 overexpression enhanced number tumor cells IMP1 knockdown cell lines saw change IMP3 levels                   blood (Figure&#194;&#160; 3A). did observe tumor cells blood vitro (data shown) (24,25). suggests IMP3 probably                 LoVo cells, attribute having euthanized mice 2.5 factor compensating IMP1 loss cells.                           weeks 8 weeks postinjection. Despite inconclusive data <br /> 2650 <br />                                                                                                                    IMP1 colorectal cancer cell xenografts <br />  <br />  <br />  primary tumor formation IMP1 knockdown xenografts,                     (Figure&#194;&#160;4B C);  spheres passaged mechan- <br /> saw significant decrease number cells circulating             ical dissociation, significant increase sphere growth blood (Figure&#194;&#160;3B). observation supports concept primary            IMP1 overexpressing cells compared controls (Figure&#194;&#160;4D). tumor size does necessarily correlate metastatic potential          suggests IMP1 overexpression promote survival clono- <br /> suggests novel role IMP1 modulating tumor dissemination                 genic growth subpopulation cells exhibiting characteristics blood.                                                                  tumor-initiating cells (TICs). <br />  <br /> IMP1 overexpression promotes colonosphere growth single                     IMP1 overexpression promotes TIC phenotype <br /> tumor cells                                                                      vivo vitro findings suggest IMP1 promote evaluate presence tumor cells enhanced clonogenic                 clonogenic growth xenograft tumors enhancement TIC <br /> growth control IMP1 overexpressing cells, dissociated xen-             phenotype. confirm findings, chose evaluate ograft tumors single cells grew individual cells serum-free,         phenotype using fluorescence-activated cell sorting. Cell sur- <br /> ultralow attachment conditions described previously (Figure&#194;&#160; 4A)              face markers CD24 CD44 shown previously iden- <br /> (20,21,27). Individual spheres counted 10&#194;&#160;days, photo-            tify TIC phenotype CRC cells (28&#226;&#8364;&#8220;31) used graphs taken. Mean sphere growth determined counting                 evaluate IMP1 overexpressing cells. particular, CRC cells number wells spheres 96 plate             exhibit enhanced CD24+CD44+ phenotype postulated TICs <br /> individual tumors condition. Mean sphere size evaluated               (31). observed significant enhancement proportion measuring average radii using ImageJ. did initially observe            CD24+CD44+ populations SW480 (Figure&#194;&#160; 5A B) increase colonosphere size number IMP1 overexpression                 LoVo (data shown) IMP1 overexpression cell lines, suggesting <br />  <br />  <br />  <br />  <br /> Fig.&#194;&#160;3.&#226;&#8364;&#8218; IMP1 modulates tumor dissemination blood. Blood collected xenograft mice euthanasia number circulating tumor cells <br /> quantified using fluorescence-activated cell sorting GFP (overexpressing cells) RFP (knockdown cells).   increase number circulating tumor cells mice harboring IMP1 overexpressing tumors. N &#226;&#8240;&#165; 3 mice group. (B) mice IMP1 knockdown tumors, significant <br /> decrease number circulating tumor cells detected blood euthanasia. *P &lt; 0.05, N &#226;&#8240;&#165; 3 mice group. <br />  <br />  <br />  <br />  <br /> Fig.&#194;&#160;4.&#226;&#8364;&#8218; IMP1 promotes colonosphere growth passaging. Xenograft tumors dissociated single cells grown serum-free, ultralow attachment <br /> conditions.   Individual tumor cells evaluated 10&#194;&#160;days sphere growth, followed mechanical disruption, passaging evaluation sphere <br /> growth spreading 14&#194;&#160;days. Scale bars&#194;&#160;=&#194;&#160;50 &#206;&#188;M. (B) difference sphere number (C) size IMP1 overexpressing tumor cells compared controls. (D) observed significant increase outgrowth mechanically passaged colonospheres IMP1 overexpressing cells compared controls. *P &lt; 0.05, N = 3 individual tumors condition. <br />  <br />                                                                                                                                                       2651 <br />  K.E.Hamilton et&#194;&#160;al. <br />  <br />  <br />  <br />  <br /> Fig.&#194;&#160;5.&#226;&#8364;&#8218; IMP1 overexpression promotes tumor-initiating phenotype. Based findings colonospheres, sought characterize effect IMP1 overexpression TIC phenotype vitro.  B) Control IMP1 overexpressing cells evaluated cell surface expression CD24 CD44, markers TICs. IMP1 overexpression dramatically enhanced proportion cells expressing high levels CD24 CD44 compared controls. *P &lt; 0.05, N = 3. (C) CD24+CD44+high cells sorted grown dimensional culture conditions. Cells passaged times, analysis CD24+CD44+high cells passage control IMP1 overexpressing cell lines. significant increase ability IMP1 <br /> overexpressing cells maintain CD24+CD44+high phenotype compared controls. *P &lt; 0.05, N = 3 passages. <br />  <br />  IMP1 does promote TIC phenotype, confer                 proapoptotic functions associated previously IMP1 <br /> prosurvival advantage cells disseminate blood.                  knockdown vitro (17,32). Using xenograft genetic models    order test IMP1 promotes stabilization TIC pheno-                CRC, demonstrate IMP1 overexpression promotes increased <br /> type course multiple passages, sorted passaged                 tumor growth, Imp1 knockdown limits tumor growth. addition, <br /> CD24+CD44+high cells control IMP1 overexpressing                    IMP1 overexpression enhances tumor dissemination blood, <br /> cell lines (Figure&#194;&#160; 5C). consistently observed IMP1 overex-               increases survival outgrowth individual tumor clones pressing cells maintained greater proportion CD24+CD44+high                  enriches population CD24+CD44+ TICs.  findings <br /> cells passaging, control cells appeared lose phe-            provide rationale IMP1 correlated <br /> notype time. supports finding IMP1 enhances                poor survival prognosis CRC patients (10,17) suggest <br /> longevity cell population colonospheres (Figure&#194;&#160;4D),           IMP1 potential driver robust, therapy-resistant TICs. cells grown dimensional culture conditions.                             previous studies indicated IMP1 loss decreased <br />    Tumor dissemination associated TIC phenotype               proliferation colony formation CRC cells vitro, epithelial mesenchymal transition (EMT) phenotype (20).                  hypothesized xenograft studies IMP1 overexpression used qRT&#226;&#8364;&#8220;PCR examine EMT IMP1 cell lines                       promote increased tumor growth potentially enhanced tumor saw significant downregulation E-cadherin IMP1                   progression. SW480 cells, observed increase tumor load <br /> overexpressed, indicating cells losing &#226;&#8364;&#732;epi-              IMP1 overexpression time course 8 weeks, trend <br /> thelial&#226;&#8364;&#8482; phenotype (Figure&#194;&#160;6A). observed trend concomitant               increased tumor load early 2.5 weeks LoVo cell tumors <br /> upregulation EMT genes vimentin, Snail, Slug Zeb1,                (Figure&#194;&#160;1B; Supplementary Figure S1B, available Carcinogenesis statistically significant (Figure&#194;&#160; 6B&#226;&#8364;&#8220;E).               Online).  SW480 cells inducible IMP1 knockdown, able detect Zeb2 cells (data shown). Taken               observed inconclusive results (Supplementary Figure S2B,  upregulation CD24+CD44+ markers downregula-                  available Carcinogenesis Online). knockdown tumors, tion E-cadherin suggest IMP1 overexpression promotes                 observed enhanced necrosis decreased viability IMP1 loss acquisition &#226;&#8364;&#732;stem-like&#226;&#8364;&#8482; phenotype loss epithelial                (Supplementary Figure S2C&#226;&#8364;&#8220;E, available Carcinogenesis Online), <br /> characteristics, support novel role high-IMP1-               surprising considering previous vitro work expressing tumor cells tumor progression.                                      observed IMP1 loss increased apoptosis (17). Increased <br />                                                                                   cell death associated IMP1 loss does   appear Discussion                                                                        lead overall decrease xenograft tumor size, suggesting <br />                                                                                   potential compensatory mechanisms IMP1 loss cells. studies suggest oncogenic role IMP1 vivo,                    turned genetic mouse model Imp1 depletion providing additional functional insight role CRC progression          intestinal tumorigenesis: conditional Imp1 knockdown mice crossed <br />  <br /> 2652 <br />                                                                                                                      IMP1 colorectal cancer cell xenografts <br />  <br />  <br />  <br />  <br /> Fig.&#194;&#160;6.&#226;&#8364;&#8218; IMP1 overexpression decreases E-cadherin expression. evaluated IMP1 overexpression promotes EMT vitro. SW480 cells overexpressing <br /> IMP1 analyzed E-cadherin, vimentin, snail, slug zeb1 gene expression order assay loss epithelial phenotype gain mesenchymal <br /> phenotype. Glyceraldehyde 3-phosphate dehydrogenase used internal control.   E-cadherin significantly decreased IMP1 overexpression. <br /> *P &lt; 0.05, N = 3. (B&#226;&#8364;&#8220;E) observed trend upregulation EMT gene IMP1 overexpressing cells. <br />  <br />  APCMin/+ mice (Imp1-loxP+/&#226;&#710;&#8217;;Villin-Cre+/&#226;&#710;&#8217;;ApcMin/+ mice).                 mechanisms act concert promote tumor dissemi- <br /> mice exhibited dramatic reduction tumor number compared                      nation blood subsequent metastatic growth. Early tumor Villin-Cre+/&#226;&#710;&#8217;ApcMin/+ littermates. Taken  combined              dissemination linked tumor cells adopting mesenchy- <br /> xenograft genetic mouse models provide novel evidence                    mal phenotype (20);  factors existence IMP1 modulates CRC tumor growth vivo.                                          subpopulation TICs (31,38) proposed critical <br />    IMP1 overexpression increased IMP1                      components cancer metastasis. evaluated clonogenic growth <br /> knockdown decreased number tumor cells circulating                  dissociating xenograft tumors evaluating growth individual <br /> blood, independent IMP1&#226;&#8364;&#8482;s effect primary xenograft tumor size               clones subsequent progeny. did observe <br /> (Figure&#194;&#160;3). recent studies reported tumor cells             significant difference number clones giving rise colo- <br /> enter circulation prior concurrent malignant growth,               nospheres IMP1 overexpression (Figure&#194;&#160; 4B), sig- <br /> challenging current dogma tumor progression localized                 nificant increase survival outgrowth IMP1 overexpressing <br /> disease followed distal metastasis (20,33,34). current                  clones postpassage (Figure&#194;&#160; 4D), suggesting IMP1 favor <br /> xenograft studies, did observe gross metastases 8 week              long-term growth expansion individual clones. <br /> time course, rule existence micrometastases                 substantiate vivo findings, explored eventual metastases arise &#226;&#8364;&#732;dormant&#226;&#8364;&#8482; TICs. second             IMP1 overexpression promotes TIC phenotype EMT vitro. <br /> possibility lack observation gross metastases model              Gene expression E-cadherin downregulated IMP1 overex- circulating tumor cells lacked appropriate distal           pression (Figure&#194;&#160;6);  did observe increase mesen- <br /> metastatic niche, studies suggest critical component           chymal genes cells vitro. E-cadherin loss signifies loss establishment metastatic lesions (35&#226;&#8364;&#8220;37). Future studies            intercellular contacts, event promote metastatic <br /> genetic mouse models required determine IMP1-mediated               phenotype (39). strikingly, observed IMP1 overexpres- <br /> tumor dissemination lead metastases additional                 sion promoted dramatic increase percentage CD24+CD44+ <br /> &#226;&#8364;&#732;hits&#226;&#8364;&#8482; required.                                                           cells (Figure&#194;&#160; 5A B), indicating IMP1 favor enhance <br />  <br />                                                                                                                                                          2653 <br />  K.E.Hamilton et&#194;&#160;al. <br />  <br />  <br />  population TICs. Furthermore, IMP1 overexpression promotes                      	13.	 Vainer,G. et&#194;&#160; al. (2008) role VICKZ proteins progression maintenance phenotype course passages                                                       colorectal carcinomas: regulating lamellipodia formation. J. Pathol., 215, <br /> (Figure&#194;&#160; 5C). intriguing IMP1 shown previ-                                                     445&#226;&#8364;&#8220;456. <br /> ously bind stabilize CD44 mRNA vitro,                        	14.	 Noubissi,F.K. et&#194;&#160;al. (2006) CRD-BP mediates stabilization betaTrCP1 <br />                                                                                                                         c-myc mRNA response beta-catenin signalling. Nature, 441, <br /> study, IMP1 depletion associated decreased invadopodia                                                     898&#226;&#8364;&#8220;901. <br /> mation (40). possible IMP1 overexpression promotes                    	15.	 St&#195;&#182;hr,N. et&#194;&#160; al. (2012) IGF2BP1 promotes cell migration regulating TIC phenotype studies stabilization CD44&#194;&#160;mRNA.                                                      MK5 PTEN signaling. Genes Dev., 26, 176&#226;&#8364;&#8220;189. <br />    Taken  studies provide novel vivo data suggesting                      	16.	 Manieri,N  et&#194;&#160;al. (2012) Igf2bp1 required induction Ptgs2 IMP1 modulates tumor growth dissemination tumor cells                                                       mRNA colonic mesenchymal stem cells mice. Gastroenterology, 143, blood. finding IMP1 overexpression promotes shift                                                   110&#226;&#8364;&#8220;21.e10. TIC phenotype explain clinical findings correlating high                        	17.	 Mongroo,P.S. et&#194;&#160; al. (2011) IMP-1 displays cross-talk K-Ras IMP1 poor prognosis clinical outcome CRC patients                                                        modulates colon cancer cell survival novel proapoptotic protein <br /> underscores potential role IMP1 early metastatic events                                                CYFIP2. Cancer Res., 71, 2172&#226;&#8364;&#8220;2182. <br />                                                                                               	18.	 King,C.E. et&#194;&#160; al. (2011) LIN28B promotes colon cancer progression marker aggressive therapeutic-resistant cell population.                                                  metastasis. Cancer Res., 71, 4260&#226;&#8364;&#8220;4268. <br />                                                                                                	19.	 Spiegelman,V.S. et&#194;&#160; al. (2000) Wnt/beta-catenin signaling induces Supplementary material                                                                                                  expression activity betaTrCP ubiquitin ligase receptor. Mol. Cell, 5, <br />                                                                                                                         877&#226;&#8364;&#8220;882. <br /> Supplementary Figures 1 2 http://carcin.oxford-                             	20.	 Rhim D. et&#194;&#160;al. (2012) EMT dissemination precede pancreatic tumor <br /> journals.org/                                                                                                           formation. Cell, 148, 349&#226;&#8364;&#8220;361. <br />                                                                                                  	21.	 Kanwar,S.S. et&#194;&#160;al. (2010) Wnt/beta-catenin pathway regulates growth <br />                                                                                                                         maintenance colonospheres. Mol. Cancer, 9, 212. <br /> Funding                                                                                           	22.	 Leibovitz  et&#194;&#160;al. (1976) Classification human colorectal adenocarci- <br />                                                                                                                         noma cell lines. Cancer Res., 36, 4562&#226;&#8364;&#8220;4569. <br /> National Institutes Health (T32 DK007066, F32 DK093207-01                                       	23.	 Noubissi,F.K. et&#194;&#160; al. (2009) Wnt signaling stimulates transcriptional  K.E.H.; K08 DK088945 D.R.; R01 DK056645-12, U01                                                                 come Hedgehog pathway stabilizing GLI1 mRNA. Cancer Res., <br /> DK085551, P30 DK050306 K.E.H., P.S.K., C.M.H., S.R.D.,                                                               69, 8572&#226;&#8364;&#8220;8578. <br /> E.T.L., J.K.-S., D.R., K.R.; CA153102 F.K.N.; AR063361                                     	24.	 Li,D. et&#194;&#160; al. (2009) IMP3 novel prognostic marker correlates V.S.S.); Hansen Foundation National Colon Colon Research                                                         colon cancer progression pathogenesis. Ann. Surg. Oncol., 16, <br /> Alliance K.R.                                                                                                      3499&#226;&#8364;&#8220;3506. <br />                                                                                                      	25.	 Lochhead,P. et&#194;&#160; al. (2012) Insulin-like growth factor 2 messenger RNA <br />                                                                                                                         binding protein 3 (IGF2BP3) marker unfavourable prognosis Acknowledgements                                                                                                        colorectal cancer. Eur. J.&#194;&#160;Cancer, 48, 3405&#226;&#8364;&#8220;3413. <br />                                                                                                       	26.	Faltas,B. (2012) Cornering metastases: therapeutic targeting circulating thank Bedenbaugh, D.Budo R.Hasan (Penn Molecular Pathology                                                     tumor cells stem cells.  Oncol., 2, 68. Imaging Facility) IHC; P.Hallberg (Penn Flow Cytometry Sorting                             	27.	 Yu,Y. et&#194;&#160;al. (2009) Elimination colon cancer stem-like cells com- <br /> Facility); D.&#194;&#160; Heitjan (Penn Biostatistics); S.Keilbaugh (Penn Molecular                                                bination curcumin FOLFOX. Transl. Oncol., 2, 321&#226;&#8364;&#8220;328. <br /> Biology Core) E.Roberston (Penn Cell Culture Core).                                                 	28.	 Weichert,W. et&#194;&#160;al. (2005) Cytoplasmic CD24 expression colorectal  <br />                                                                                                                         <span id='am-13' about='obo:IMR_0100177' typeof='obo:IMR_0100022 owl:Thing obo:IMR_0000947 obo:IMR_0001359 obo:IMR_0000001 obo:IMR_0001362'><span id='am-14' property="rdfs:label" content="ceramide" datatype="xsd:string"></span><span id='am-15' property="oboInOwl:hasDbXref" content="KEGG:C00195" datatype="xsd:string"></span><span id='am-16' property="rdfs:label" content="cer" datatype="xsd:string"></span><span id='am-17' property="rdfs:label" content="N-Acylsphingosine" datatype="xsd:string"></span><span id='am-18' property="oboInOwl:id" content="IMR:0100177" datatype="xsd:string"></span><span id='am-19' property="rdfs:label" content="C2-ceramide" datatype="xsd:string"></span><span id='am-20' property="oboInOwl:hasExactSynonym" content="N-Acylsphingosine" datatype="xsd:string"></span><span id='am-21' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-22' property="oboInOwl:hasExactSynonym" content="cer" datatype="xsd:string"></span><span id='am-23' property="oboInOwl:hasExactSynonym" content="C2-ceramide" datatype="xsd:string"></span>cer</span> independently correlates shortened patient survival. Clin. Cancer <br /> Conflict Statement: declared.                                                                          Res., 11, 6574&#226;&#8364;&#8220;6581. <br />                                                                                                          	29.	 Choi,D. et&#194;&#160;al. (2009) Cancer stem cell markers CD133 CD24 correlate <br /> References                                                                                                              invasiveness differentiation colorectal adenocarcinoma. World <br />                                                                                                                         J.&#194;&#160;Gastroenterol., 15, 2258&#226;&#8364;&#8220;2264. <br /> 	 1.	Leeds,P. et&#194;&#160; al. (1997) Developmental regulation CRD-BP, RNA-                                  	30.	 Herrmann  et&#194;&#160;al. (2010) Highly efficient elimination colorectal tumor- <br />         binding protein stabilizes c-myc mRNA vitro. Oncogene, 14,                                              initiating cells EpCAM/CD3-bispecific antibody engaging human T <br />         1279&#226;&#8364;&#8220;1286.                                                                                                      cells. PLoS  5, e13474. <br /> 	 2.	Ross F. et&#194;&#160; al. (1997) Characterization beta-actin mRNA zipcode-                               	31.	 Yeung,T.M. et&#194;&#160;al. (2010) Cancer stem cells colorectal cancer-derived <br />         binding protein. Mol. Cell. Biol., 17, 2158&#226;&#8364;&#8220;2165.                                                               cell lines. Proc. Natl Acad. Sci. USA, 107, 3722&#226;&#8364;&#8220;3727. <br /> 	 3.	Doyle,G  et&#194;&#160; al. (1998) c-myc coding region determinant-binding                                  	32.	 Boyerinas,B. et&#194;&#160;al. (2012) Let-7 modulates acquired resistance ovarian <br />         protein: member family KH domain RNA-binding proteins.                                                cancer Taxanes  <br /> </body></html>